These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6987871)

  • 21. [Hafnia alvei septicemia with shock and DIC in an adult with postoperative lung cancer].
    Masaki H; Ide M; Mochinaga S; Kawachi Y; Fukuda K; Tsukamoto N; Watanabe K; Takahashi A; Nagatake T; Matsumoto K
    Kansenshogaku Zasshi; 1991 Sep; 65(9):1205-10. PubMed ID: 1761901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteremia in childhood cancer.
    Celkan T; Ozkan A; Apak H; Diren S; Can G; Yuksel L; Yildiz I
    J Trop Pediatr; 2002 Dec; 48(6):373-7. PubMed ID: 12521283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
    Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of children with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Vandepitte WP; Berge J; Andersson R
    J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S129-39. PubMed ID: 25509707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Septic shock in bacteremic patients: risk factors, features and prognosis.
    Leibovici L; Drucker M; Konigsberger H; Samra Z; Harrari S; Ashkenazi S; Pitlik SD
    Scand J Infect Dis; 1997; 29(1):71-5. PubMed ID: 9112302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
    Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
    J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pseudomonas aeruginosa bacteremia associated with hematologic disorders [I]. Predisposing factors and clinical manifestations].
    Funada H; Machi T; Matsuda T
    Kansenshogaku Zasshi; 1989 Aug; 63(8):867-73. PubMed ID: 2507686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical importance of "breakthrough" bacteremia.
    Weinstein MP; Reller LB
    Am J Med; 1984 Feb; 76(2):175-80. PubMed ID: 6695945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raoultella planticola bacteremia-induced fatal septic shock following burn injury.
    Yumoto T; Naito H; Ihoriya H; Tsukahara K; Ota T; Watanabe T; Nakao A
    Ann Clin Microbiol Antimicrob; 2018 May; 17(1):19. PubMed ID: 29728100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials.
    Burnham JP; Micek ST; Kollef MH
    PLoS One; 2017; 12(7):e0180247. PubMed ID: 28678812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
    Kleinhendler E; Cohen MJ; Moses AE; Paltiel O; Strahilevitz J; Cahan A
    Int J Antimicrob Agents; 2018 Jan; 51(1):71-76. PubMed ID: 28705670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nosocomial bacteremia caused by Serratia marcescens: analysis of 44 cases].
    Domínguez A; Arribas JR; Folgueira MD; Peña P; Luengo S; Peña JM; Vázquez JJ
    Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):553-9. PubMed ID: 2099856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gram negative sepsis and shock.
    Landesman SH; Gorbach SL
    Orthop Clin North Am; 1978 Jul; 9(3):611-25. PubMed ID: 358039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibiotic treatment of septicemias caused by gram-negative rods].
    Monnier J
    Rev Med Liege; 1970 Nov; 25(21):688-702. PubMed ID: 5474691
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathophysiology of bacteremia.
    McCabe WR; Treadwell TL; De Maria A
    Am J Med; 1983 Jul; 75(1B):7-18. PubMed ID: 6349346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.
    Zilberberg MD; Shorr AF; Micek ST; Vazquez-Guillamet C; Kollef MH
    Crit Care; 2014 Nov; 18(6):596. PubMed ID: 25412897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-laboratory parameters of bacteremia and sepsis caused by Escherichia coli].
    Skerk V; Bobinac E; Popović-Uroić T; Schönwald S
    Lijec Vjesn; 1993; 115(3-4):85-9. PubMed ID: 8231622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli.
    Parry MF; Neu HC
    Am J Med; 1978 Jun; 64(6):961-6. PubMed ID: 247895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gram-negative septicemia in patients with hematologic malignancies.
    Todeschini G; Vinante F; Benini F; Perini A; Pasini F; Cetto G
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):327-31. PubMed ID: 6368245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.